Daily Supplements May Slow 'Dry' Form of Macular Degeneration

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on July 22, 2024.

By Dennis Thompson HealthDay Reporter

MONDAY, July 22, 2024 -- Daily supplements can slow loss of vision related to late-stage “dry” age-related macular degeneration (AMD), a new study finds.

The rate of dry AMD progression into a key eye region slowed by about 55% over an average three years for late-stage patients who took a daily blend of antioxidants and minerals, researchers reported July 16 in the journal Ophthalmology.

Prior results have shown that supplements slow the progression from intermediate to late AMD, said lead researcher Dr. Tiarnan Keenan, a staff clinician with the National Eye Institute.

“Our analysis shows that taking … supplements can also slow disease progression in people with late dry AMD,” Keenan said in an institute news release.

The supplements include the antioxidants vitamin C, E, beta-carotene, lutein and zeaxanthin, along with the minerals zinc and copper.

Dry AMD is the most common form of macular degeneration, affecting nine out of 10 people with the eye condition, the Cleveland Clinic says.

Dry AMD occurs when small yellow deposits of fatty proteins called drusen start to develop along the light-sensing retina at the back of a person’s eye, researchers explained in background notes.

These deposits cause the loss of light-sensitive cells in the retina, a condition called “geographic atrophy” that slowly expands over time. As a result, people progressively lose their central vision.

The new study focused on the fovea, a small depression at the center of the retina that is responsible for sharp central vision.

Many people with dry AMD first develop geographic atrophy outside the fovea, and only lose their central vision when AMD encroaches into the fovea, researchers noted.

For the new study, researchers reviewed data on more than 1,200 participants in two clinical trials testing the effectiveness of supplements to slow AMD progression. The trials were funded by the federal government.

The analysis showed that for people whose dry AMD hadn’t affected the fovea, taking supplements could slow the progression of the eye disease to that crucial region.

“Our high acuity central vision is essential for tasks like reading and driving,” Keenan said. “Given that there are few therapeutic options for people with late-stage dry AMD to retain or restore their vision, antioxidant supplementation is a simple step that may slow central vision loss, even for those with late disease.”

Researchers plan to conduct a follow-up clinical trial to confirm these results, Keenan added.

Sources

  • National Eye Institute, news release, July 16, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-07-23 03:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords